Profil
Russell P. Wilson occupe actuellement le poste de premier vice-président chargé du développement commercial chez Novavax, Inc. Il a précédemment occupé les postes de directeur financier et de vice-président chez Supernus Pharmaceuticals, Inc, de directeur financier, de secrétaire et de premier vice-président chez Intercell USA, Inc et de directeur juridique chez North American Vaccine, Inc. Il a obtenu un MBA et un diplôme d'études supérieures de l'université de Virginie et un diplôme de premier cycle de l'université de Princeton.
Anciens postes connus de Russell Wilson
| Sociétés | Poste | Fin |
|---|---|---|
| NOVAVAX, INC. | Chief Tech/Sci/R&D Officer | 28/03/2012 |
| IOMAI CORPORATION | Director of Finance/CFO | 01/08/2008 |
North American Vaccine, Inc.
 North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million. | General Counsel | 01/01/2000 |
| SUPERNUS PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Formation de Russell Wilson
| University of Virginia | Graduate Degree |
| Princeton University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NOVAVAX, INC. | Health Technology |
| SUPERNUS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million. | Health Technology |
Intercell USA, Inc.
 Intercell USA, Inc. BiotechnologyHealth Technology Intercell USA, Inc. discovers and develops vaccines and immune system stimulants. The vaccine patch enhances the efficacy of existing vaccines, enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was founded by Gregory M. Glenn and Dean P. Lewis in September 1997 and is headquartered in Gaithersburg, MD. | Health Technology |
